StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS – Free Report) in a research note published on Wednesday morning. The brokerage issued a hold rating on the stock.
Milestone Scientific Stock Down 0.8 %
Shares of MLSS opened at $0.97 on Wednesday. The firm has a market cap of $75.10 million, a price-to-earnings ratio of -9.73 and a beta of 0.88. The company’s fifty day moving average is $0.83 and its 200-day moving average is $0.72. Milestone Scientific has a 12 month low of $0.52 and a 12 month high of $1.19.
Milestone Scientific (NYSE:MLSS – Get Free Report) last posted its earnings results on Wednesday, May 15th. The company reported ($0.02) EPS for the quarter. Milestone Scientific had a negative return on equity of 93.64% and a negative net margin of 74.50%. The business had revenue of $2.25 million for the quarter.
Milestone Scientific Company Profile
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Featured Stories
- Five stocks we like better than Milestone Scientific
- 3 Stocks to Consider Buying in October
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- The Role Economic Reports Play in a Successful Investment Strategy
- MarketBeat Week in Review – 8/12 – 8/16
- Quiet Period Expirations Explained
- JD.com Earnings Surprise: China’s Outlook Better Than Expected
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
